UK patients granted early access for radioligand therapy in advanced prostate cancer
Patients with the life-threatening disease are set to benefit from the Early Access to Medicines Scheme
Read MorePatients with the life-threatening disease are set to benefit from the Early Access to Medicines Scheme
Read MoreThe government’s planned ‘Road to Recovery’ will have a new focus on prevention
Read MoreCertain areas in the UK have been experiencing a significant increase in COVID-19 cases in recent days
Read MoreThe UK government is urged to be more mindful of children and young people who have mental health issues, following the publication of the NHS Elective Recovery Plan
Read MoreStudy reveals that many with an increased risk of cancer were excluded from the potential for monitoring
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
